These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 11355290

  • 21. A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust.
    Frye BC, Quartucci C, Rakete S, Grubanovic A, Höhne K, Mangold F, Gieré R, Müller-Quernheim J, Zissel G.
    Chest; 2021 Mar; 159(3):1084-1093. PubMed ID: 32926872
    [Abstract] [Full Text] [Related]

  • 22. Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program.
    Donovan EP, Kolanz ME, Galbraith DA, Chapman PS, Paustenbach DJ.
    Int Arch Occup Environ Health; 2007 Nov; 81(2):165-78. PubMed ID: 17483959
    [Abstract] [Full Text] [Related]

  • 23. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
    Cher DJ, Deubner DC, Kelsh MA, Chapman PS, Ray RM.
    Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
    [Abstract] [Full Text] [Related]

  • 24. Estimating historical exposures of workers in a beryllium manufacturing plant.
    Sanderson WT, Petersen MR, Ward EM.
    Am J Ind Med; 2001 Feb; 39(2):145-57. PubMed ID: 11170157
    [Abstract] [Full Text] [Related]

  • 25. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L, Ringen K, Bingham E, Dement J, Takaro T, McGowan W, Chen A, Quinn P.
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [Abstract] [Full Text] [Related]

  • 26. Beryllium particulate exposure and disease relations in a beryllium machining plant.
    Kelleher PC, Martyny JW, Mroz MM, Maier LA, Ruttenber AJ, Young DA, Newman LS.
    J Occup Environ Med; 2001 Mar; 43(3):238-49. PubMed ID: 11285872
    [Abstract] [Full Text] [Related]

  • 27. Beryllium health effects in the era of the beryllium lymphocyte proliferation test.
    Maier LA.
    Appl Occup Environ Hyg; 2001 May; 16(5):514-20. PubMed ID: 11370931
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of beryllium sensitization among Department of Defense conventional munitions workers at low risk for exposure.
    Mikulski MA, Sanderson WT, Leonard SA, Lourens S, Field RW, Sprince NL, Fuortes LJ.
    J Occup Environ Med; 2011 Mar; 53(3):258-65. PubMed ID: 21293302
    [Abstract] [Full Text] [Related]

  • 29. Beryllium hypersensitivity and chronic beryllium lung disease.
    Santo Tomas LH.
    Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
    [Abstract] [Full Text] [Related]

  • 30. A model for optimization of biomarker testing frequency to minimize disease and cost: example of beryllium sensitization testing.
    Judd NL, Griffith WC, Takaro T, Faustman EM.
    Risk Anal; 2003 Dec; 23(6):1211-20. PubMed ID: 14641896
    [Abstract] [Full Text] [Related]

  • 31. Optimizing BeLPT criteria for beryllium sensitization.
    Middleton DC, Fink J, Kowalski PJ, Lewin MD, Sinks T.
    Am J Ind Med; 2008 Mar; 51(3):166-72. PubMed ID: 18181198
    [Abstract] [Full Text] [Related]

  • 32. Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada.
    Ribeiro M, Fritscher LG, Al-Musaed AM, Balter MS, Hoffstein V, Mazer BD, Maier LA, Liss GM, Tarlo SM.
    Lung; 2011 Jun; 189(3):233-41. PubMed ID: 21400234
    [Abstract] [Full Text] [Related]

  • 33. Beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch LS, Ringen K, Dement J, Bingham E, Quinn P, Shorter J, Fisher M.
    Am J Ind Med; 2013 Oct; 56(10):1125-36. PubMed ID: 23794247
    [Abstract] [Full Text] [Related]

  • 34. Beryllium: a modern industrial hazard.
    Kreiss K, Day GA, Schuler CR.
    Annu Rev Public Health; 2007 Oct; 28():259-77. PubMed ID: 17094767
    [Abstract] [Full Text] [Related]

  • 35. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
    McCawley MA, Kent MS, Berakis MT.
    Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
    Kolanz ME, Madl AK, Kelsh MA, Kent MS, Kalmes RM, Paustenbach DJ.
    Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility.
    Stange AW, Hilmas DE, Furman FJ, Gatliffe TR.
    Appl Occup Environ Hyg; 2001 Mar; 16(3):405-17. PubMed ID: 11297055
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.